Leukocyte telomere length in women with and without polycystic ovary syndrome: a systematic review and meta-analysis

References

• Palomba S, Santagni S, Falbo A, et al. Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Womens Health. 2015;7:745–763.
   PubMed Web of Science ®Google Scholar
• Hernández-Jiménez JL, Barrera D, Espinoza-Simón E, et al. Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance. Gynecol Endocrinol. 2022;38(1):2–9.
   PubMed Web of Science ®Google Scholar
• Pérez-López FR, Ornat L, López-Baena MT, et al. Circulating kisspeptin and anti-müllerian hormone levels, and insulin resistance in women with polycystic ovary syndrome: a systematic review, Meta-analysis, and Meta-regression. Eur J Obstet Gynecol Reprod Biol. 2021;260:85–98.
   PubMed Web of Science ®Google Scholar
• Falcetta P, Benelli E, Molinaro A, et al. Effect of aging on clinical features and metabolic complications of women with polycystic ovary syndrome. J Endocrinol Invest. 2021;44(12):2725–2733.
   PubMed Web of Science ®Google Scholar
• de Medeiros SF, Yamamoto MMW, Souto de Medeiros MA, et al. Changes in clinical and biochemical characteristics of polycystic ovary syndrome with advancing age. Endocr Connect. 2020;9(2):74–89.
   PubMed Web of Science ®Google Scholar
• Ajmal N, Khan SZ, Shaikh R. Polycystic ovary syndrome (PCOS) and genetic predisposition: a review article. Eur J Obstet Gynecol Reprod Biol X. 2019;3:100060.
   PubMedGoogle Scholar
• Liu X, Xu M, Qian M, et al. CYP17 T/C (rs74357) gene polymorphism contributes to polycystic ovary syndrome susceptibility: evidence from a Meta-analysis. Endocr Connect. 2021;10:R305–R316.
   PubMed Web of Science ®Google Scholar
• Wang L, Qi H, Baker PN, et al. Altered circulating inflammatory cytokines are associated with anovulatory polycystic ovary syndrome (PCOS) women resistant to clomiphene citrate treatment. Med Sci Monit. 2017;23:1083–1089.
   PubMed Web of Science ®Google Scholar
• Artimani T, Karimi J, Mehdizadeh M, et al. Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in polycystic ovary syndrome (PCOS). Gynecol Endocrinol. 2018;34(2):148–152.
   PubMed Web of Science ®Google Scholar
• Popovic M, Sartorius G, Christ-Crain M. Chronic low-grade inflammation in polycystic ovary syndrome: is there a (patho)-physiological role for interleukin-1? Semin Immunopathol. 2019;41(4):447–459.
   PubMed Web of Science ®Google Scholar
• Murri M, Luque-Ramírez M, Insenser M, et al. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and Meta-analysis. Hum Reprod Update. 2013;19(3):268–288.
   PubMed Web of Science ®Google Scholar
• Gharaei R, Mahdavinezhad F, Samadian E, et al. Antioxidant supplementations ameliorate PCOS complications: a review of RCTs and insights into the underlying mechanisms. J Assist Reprod Genet. 2021;38(11):2817–2831.
   PubMed Web of Science ®Google Scholar
• Ozturk S, Sozen B, Demir N. Telomere length and telomerase activity during oocyte maturation and early embryo development in mammalian species. Mol Hum Reprod. 2014;20(1):15–30.
   PubMed Web of Science ®Google Scholar
• Rocca MS, Foresta C, Ferlin A. Telomere length: lights and shadows on their role in human reproduction. Biol Reprod. 2019;100(2):305–317.
   PubMed Web of Science ®Google Scholar
• Condorelli RA, Calogero AE, Di Mauro M, et al. Androgen excess and metabolic disorders in women with PCOS: beyond the body mass index. J Endocrinol Invest. 2018;41(4):383–388.
   PubMed Web of Science ®Google Scholar
• Armanios M. Telomeres and age-related disease: how telomere biology informs clinical paradigms. J Clin Invest. 2013;123(3):996–1002.
   PubMed Web of Science ®Google Scholar
• Blackburn EH, Epel ES, Lin J. Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection. Science. 2015;350(6265):1193–1198.
   PubMed Web of Science ®Google Scholar
• Herrmann M, Pusceddu I, März W, et al. Telomere biology and age-related diseases. Clin Chem Lab Med. 2018;56(8):1210–1222.
   PubMed Web of Science ®Google Scholar
• Peng X, Huang J, Xia S, et al. Association of leukocyte telomere length with metabolic syndrome in type 2 diabetes mellitus. J Res Med Sci. 2021;26(1):43.
   PubMed Web of Science ®Google Scholar
• Qiao J, Feng HL. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update. 2011;17(1):17–33.
   PubMed Web of Science ®Google Scholar
• Al Dehaini DMB, Al-Bustan SA, Ali ME, et al. Shortening of the leucocytes’ telomeres length in T2DM independent of age and telomerase activity. Acta Diabetol. 2020;57(11):1287–1295.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–47.
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D, et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–488.
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in Meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
   PubMedGoogle Scholar
• Hedges LV. Fitting categorical models to effect sizes from a series of experiments. J Educ Stat. 1982;7(2):119–137.
   Google Scholar
• Deeks JJ, Higgins JPT, Altman DG, 2010. Chapter 10. Analysing data and undertaking meta-analyses. [accessibility verified March 2, 2021]. Available from: https://training.cochrane.org/handbook/current/chapter-10
   Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in Meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Kalyan S, Patel MS, Kingwell E, et al. Competing factors link to bone health in polycystic ovary syndrome: Chronic Low-Grade inflammation takes a toll. Sci Rep. 2017;7(1):3432.
   PubMedGoogle Scholar
• Li Q, Du J, Feng R, et al. A possible new mechanism in the pathophysiology of polycystic ovary syndrome (PCOS): the discovery that leukocyte telomere length is strongly associated with PCOS. J Clin Endocrinol Metab. 2014;99(2):E 234–240.
   Web of Science ®Google Scholar
• Pedroso DCC, Miranda-Furtado CL, Kogure GS, et al. Inflammatory biomarkers and telomere length in women with polycystic ovary syndrome. Fertil Steril. 2015;103(2):542–547.e2.
   PubMed Web of Science ®Google Scholar
• Velazquez ME, Millan AL, Rojo M, et al. Telomere length differently associated to obesity and hyperandrogenism in women with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021;12:604215.
   PubMed Web of Science ®Google Scholar
• Wang C, Shen F, Zhu Y, et al. Telomeric repeat-containing RNA (TERRA) related to polycystic ovary syndrome (PCOS). Clin Endocrinol. 2017;86(4):552–559.
   PubMed Web of Science ®Google Scholar
• Wei D, Xie J, Yin B, et al. Significantly lengthened telomere in granulosa cells from women with polycystic ovarian syndrome (PCOS). J Assist Reprod Genet. 2017;34(7):861–866.
   PubMed Web of Science ®Google Scholar
• Li Y, Deng B, Ouyang N, et al. Telomere length is short in PCOS and oral contraceptive does not affect the telomerase activity in granulosa cells of patients with PCOS. J Assist Reprod Genet. 2017;34(7):849–859.
   PubMed Web of Science ®Google Scholar
• Pedroso DCC, Santana VP, Donaires FS, et al. Telomere length and telomerase activity in immature oocytes and cumulus cells of women with polycystic ovary syndrome. Reprod Sci. 2020;27(6):1293–1303.
   PubMed Web of Science ®Google Scholar
• Srinivas N, Rachakonda S, Kumar R. Telomeres and telomere length: a general overview. Cancers (Basel). 2020;12(3):558.
   PubMed Web of Science ®Google Scholar
• O’Donovan A, Pantell MS, Puterman E, et al. Cumulative inflammatory load is associated with short leukocyte telomere length in the health, aging and body composition study. PLoS One. 2011;6(5):e19687.
   PubMed Web of Science ®Google Scholar
• Wong JYY, De Vivo I, Lin X, et al. The relationship between inflammatory biomarkers and telomere length in an occupational prospective cohort study. PLoS One. 2014;9(1):e87348.
   PubMed Web of Science ®Google Scholar
• Verhulst S, Dalgård C, Labat C, et al. A short leucocyte telomere length is associated with development of insulin resistance. Diabetologia. 2016;59(6):1258–1265.
   PubMed Web of Science ®Google Scholar
• Gao X, Li S, Dong S, et al. Association between body weight and telomere length is predominantly mediated through C-Reactive protein. J Clin Endocrinol Metab. 2021;106(11):e4634–e4640.
   PubMed Web of Science ®Google Scholar
• Gavia-García G, Rosado-Pérez J, Arista-Ugalde TL, et al. Telomere length and oxidative stress and its relation with metabolic syndrome components in the aging. Biology (Basel). 2021;10(4):253.
   PubMedGoogle Scholar
• Huang Z, Liu C, Ruan Y, et al. Dynamics of leukocyte telomere length in adults aged 50 and older: a longitudinal population-based cohort study. Geroscience. 2021;43(2):645–654.
   PubMed Web of Science ®Google Scholar
• Blum MR, Popat RA, Nagy A, et al. Using metabolic markers to identify insulin resistance in premenopausal women with and without polycystic ovary syndrome. J Endocrinol Invest. 2021;44(10):2123–2130.
   PubMed Web of Science ®Google Scholar
• Gao L, Li M, Wang Y, et al. Overweight and high serum total cholesterol were risk factors for the outcome of IVF/ICSI cycles in PCOS patients and a PCOS-specific predictive model of live birth rate was established. J Endocrinol Invest. 2020;43(9):1221–1228.
   PubMed Web of Science ®Google Scholar
• Cai WY, Gao JS, Luo X, et al. Effects of metabolic abnormalities, hyperandrogenemia and clomiphene on liver function parameters among chinese women with polycystic ovary syndrome: results from a randomized controlled trial. J Endocrinol Invest. 2019;42(5):549–555.
   PubMed Web of Science ®Google Scholar
• Mu L, Li R, Lai Y, et al. Adipose insulin resistance is associated with cardiovascular risk factors in polycystic ovary syndrome. J Endocrinol Invest. 2019;42(5):541–548.
   PubMed Web of Science ®Google Scholar
• Meczekalski B, Pérez-Roncero GR, López-Baena MT, et al. The polycystic ovary syndrome and gynecological cancer risk. Gynecol Endocrinol. 2020;36(4):289–293.
   PubMed Web of Science ®Google Scholar
• Prabhu BN, Kanchamreddy SH, Sharma AR, et al. Conceptualization of functional single nucleotide polymorphisms of polycystic ovarian syndrome genes: an in silico approach. J Endocrinol Invest. 2021;44(8):1783–1793.
   PubMed Web of Science ®Google Scholar
• Mario FM, Graff SK, Spritzer PM. Habitual physical activity is associated with improved anthropometric and androgenic profile in PCOS: a cross-sectional study. J Endocrinol Invest. 2017;40(4):377–384.
   PubMed Web of Science ®Google Scholar
• Ribeiro VB, Pedroso DCC, Kogure GS, et al. Short-Term aerobic exercise did not change telomere length while it reduced testosterone levels and obesity indexes in PCOS: a randomized controlled clinical trial study. Int J Environ Res Public Health. 2021;18(21):11274.
   PubMed Web of Science ®Google Scholar
• Miranda-Furtado CL, Ramos FK, Kogure GS, et al. A nonrandomized trial of progressive resistance training intervention in women with polycystic ovary syndrome and its implications in telomere content. Reprod Sci. 2016;23(5):644–654.
   PubMed Web of Science ®Google Scholar
• Cristofari G, Lingner J. Telomere length homeostasis requires that telomerase levels are limiting. EMBO J. 2006;25(3):565–574.
   PubMed Web of Science ®Google Scholar
• Yasumoto S, Kunimura C, Kikuchi K, et al. Telomerase activity in normal human epithelial cells. Oncogene. 1996;13(2):433–439.
   PubMed Web of Science ®Google Scholar
• Murnane JP, Sabatier L, Marder BA, et al. Telomere dynamics in an immortal cell line. EMBO J. 1994;13(20):4953–4962.
   PubMed Web of Science ®Google Scholar
• Samassekou O, Gadji M, Drouin R, et al. Sizing the ends: normal length of human telomeres. Ann Anat. 2010;192(5):284–291.
   PubMed Web of Science ®Google Scholar
• Moghetti P, Tosi F. Insulin resistance and PCOS: chicken or egg? J Endocrinol Invest. 2021;44(2):233–244.
   PubMed Web of Science ®Google Scholar